SCHEMBL21180772

SCHEMBL21180772

COC(=O)c1cc(NC(O)c2cc(NC(=O)c3cccn3C)cn2C)cn1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 1/20 0.41
NPC1 O15118 5/20 0.41
RAB9A P51151 5/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
PKM P14618 3/20 0.41
NFKB1 P19838 2/20 0.41
NFKB2 Q00653 2/20 0.41
RELA Q04206 2/20 0.41
MAPT P10636 1/20 0.41
IMPDH2 P12268 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
GRM1 Q13255 1/20 0.38
TAS2R8 Q9NYW2 1/20 0.37
HPGD P15428 3/20 0.37
POLB P06746 2/20 0.36
PRKCA P17252 1/20 0.36
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22422735 0.89 P2RY12 (0.44) P2RY12NPC1RAB9ASMN1; SMN2PKM
SCHEMBL2391593 0.88 NPC1 (0.50) P2RY12NPC1RAB9ASMN1; SMN2PKM
SCHEMBL20833643 0.86 NPC1 (0.49) P2RY12NPC1RAB9ASMN1; SMN2PKM
SCHEMBL2388881 0.86 NPC1 (0.49) P2RY12NPC1RAB9ASMN1; SMN2PKM
SCHEMBL2392790 0.78 HDAC1 (0.49) NPC1RAB9ASMN1; SMN2PKMNFKB1
SCHEMBL20833589 0.77 HDAC1 (0.42) P2RY12NPC1RAB9ASMN1; SMN2PKM
SCHEMBL12256151 0.77 PKM (0.43) P2RY12NPC1RAB9ASMN1; SMN2PKM
SCHEMBL12307070 0.76 HDAC1 (0.48) NPC1RAB9ASMN1; SMN2PKMNFKB1
SCHEMBL27016029 0.76 HDAC1 (0.48) NPC1RAB9ASMN1; SMN2PKMNFKB1
SCHEMBL2391009 0.76 HDAC1 (0.48) P2RY12NPC1RAB9ASMN1; SMN2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10358439-B2 DNA binding agents with a minor groove binding tail BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10358439-B2 DNA binding agents with a minor groove binding tail TOP2B, TOP2A, TOP1 P2RY12 3975/4885NPC1 995/4885RAB9A 2785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.